Ching W. Chong,Robert Kuehl,Heow Tan,Harisha Atluri
申请号：
US15467414
公开号：
US20170258729A1
申请日:
2017.03.23
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Described herein are pharmaceutical formulations of Brutons tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one. Also disclosed are methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
